# A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

> **NCT02704429** · PHASE2 · COMPLETED · sponsor: **Principia Biopharma, a Sanofi Company** · enrollment: 42 (actual)

## Conditions studied

- Pemphigus Vulgaris

## Interventions

- **DRUG:** PRN1008

## Key facts

- **NCT ID:** NCT02704429
- **Lead sponsor:** Principia Biopharma, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-22
- **Primary completion:** 2019-12-18
- **Final completion:** 2020-01-10
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704429, "A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02704429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*